← Back to Search

Procedure

Surgery for Constipation (PROD Trial)

N/A
Recruiting
Led By Ghazaleh Rostami Nia, MD
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Rectal hypermobility defined as a compression ratio greater than 50% according to ultrasound
Patient planning on undergoing surgery for the repair of pelvic organ prolapse
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months post-operatively
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare two surgical procedures for treating the inability to completely empty the bowels in women. One procedure is called laparoscopic abdominal ventral rectopexy, which is a common

Who is the study for?
This trial is for adult women suffering from obstructive defecatory syndrome (ODS), who often strain, can't fully empty their bowels, or need to manually assist bowel movements. Participants must be able to complete study assessments and provide consent, have rectal hypermobility as shown by ultrasound, and commit to a 24-month follow-up.
What is being tested?
The trial compares two surgeries for ODS: laparoscopic abdominal ventral rectopexy and transvaginal sacrospinous rectopexy. Women will be randomly assigned one of these procedures and followed up at intervals over two years to assess symptoms and surgical success.
What are the potential side effects?
Potential side effects may include discomfort or pain at the surgery site, bleeding, infection risk post-surgery, possible pelvic organ injury during operation, and general anesthesia risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My ultrasound shows my rectum moves more than normal.
Select...
I am planning to have surgery for pelvic organ prolapse.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months post-operatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Degree of rectal hypermobility measured via ultrasound
Secondary study objectives
Global improvement in bladder function
Pelvic Floor Distress Inventory (PFDI) - CRADI
Pelvic Floor Distress Inventory (PFDI) - POPDI
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Transvaginal sacrospinous rectopexyExperimental Treatment1 Intervention
Group II: Laparoscopic abdominal ventral rectopexyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityOTHER
1,086 Previous Clinical Trials
1,147,231 Total Patients Enrolled
1 Trials studying Pelvic Organ Prolapse
170 Patients Enrolled for Pelvic Organ Prolapse
NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,526 Total Patients Enrolled
1 Trials studying Pelvic Organ Prolapse
114 Patients Enrolled for Pelvic Organ Prolapse
University of PittsburghOTHER
1,789 Previous Clinical Trials
16,359,507 Total Patients Enrolled
4 Trials studying Pelvic Organ Prolapse
486 Patients Enrolled for Pelvic Organ Prolapse
~77 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top